Soros Capital Management LLC raised its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 510.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,619 shares of the biotechnology company's stock after buying an additional 8,043 shares during the quarter. Soros Capital Management LLC's holdings in Axon Enterprise were worth $5,717,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in the company. Capital World Investors boosted its holdings in Axon Enterprise by 86.4% in the 4th quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company's stock valued at $1,079,145,000 after purchasing an additional 841,772 shares during the period. Alliancebernstein L.P. raised its holdings in Axon Enterprise by 273.8% in the 4th quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock valued at $659,128,000 after acquiring an additional 812,337 shares in the last quarter. Norges Bank acquired a new stake in shares of Axon Enterprise during the 4th quarter worth $482,081,000. GQG Partners LLC bought a new position in shares of Axon Enterprise in the fourth quarter worth $478,349,000. Finally, Vanguard Group Inc. lifted its position in Axon Enterprise by 3.4% during the fourth quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company's stock worth $5,019,886,000 after purchasing an additional 275,959 shares during the period. Institutional investors own 79.08% of the company's stock.
Analyst Ratings Changes
A number of brokerages have recently weighed in on AXON. Northcoast Research downgraded shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. TD Cowen initiated coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a "buy" rating and a $700.00 price target for the company. JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Craig Hallum downgraded shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. Finally, Barclays reissued a "hold" rating on shares of Axon Enterprise in a research note on Monday, March 10th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $626.45.
Check Out Our Latest Stock Analysis on AXON
Axon Enterprise Trading Up 2.2 %
Shares of AXON traded up $13.11 during mid-day trading on Friday, reaching $603.78. 556,214 shares of the company were exchanged, compared to its average volume of 777,156. The business has a 50 day simple moving average of $545.51 and a two-hundred day simple moving average of $570.72. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99. The stock has a market capitalization of $47.00 billion, a PE ratio of 156.02, a PEG ratio of 5.17 and a beta of 1.13. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.
Insiders Place Their Bets
In related news, Director Jeri Williams sold 307 shares of the firm's stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares of the company's stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the business's stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $540.99, for a total value of $5,409,900.00. Following the completion of the transaction, the chief executive officer now directly owns 3,063,982 shares in the company, valued at approximately $1,657,583,622.18. This trade represents a 0.33 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 6.10% of the company's stock.
About Axon Enterprise
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Stories

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.